AU2009901425A0 - Compositions and methods for treatment of aortic fibrosis - Google Patents

Compositions and methods for treatment of aortic fibrosis

Info

Publication number
AU2009901425A0
AU2009901425A0 AU2009901425A AU2009901425A AU2009901425A0 AU 2009901425 A0 AU2009901425 A0 AU 2009901425A0 AU 2009901425 A AU2009901425 A AU 2009901425A AU 2009901425 A AU2009901425 A AU 2009901425A AU 2009901425 A0 AU2009901425 A0 AU 2009901425A0
Authority
AU
Australia
Prior art keywords
compositions
treatment
methods
aortic fibrosis
aortic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2009901425A
Inventor
Karen Annette Duggan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectus Biosystems Pty Ltd
Original Assignee
Vectus Biosystems Pty Ltd
Filing date
Publication date
Application filed by Vectus Biosystems Pty Ltd filed Critical Vectus Biosystems Pty Ltd
Publication of AU2009901425A0 publication Critical patent/AU2009901425A0/en
Priority to ES10757953.4T priority Critical patent/ES2462501T3/en
Priority to CA2757076A priority patent/CA2757076C/en
Priority to US13/262,064 priority patent/US8729020B2/en
Priority to NZ595726A priority patent/NZ595726A/en
Priority to EP10757953.4A priority patent/EP2413954B1/en
Priority to SG2011070778A priority patent/SG174966A1/en
Priority to MYPI2011004649A priority patent/MY180681A/en
Priority to AU2010230862A priority patent/AU2010230862B2/en
Priority to KR1020117025945A priority patent/KR101627008B1/en
Priority to MX2011010341A priority patent/MX2011010341A/en
Priority to DK10757953.4T priority patent/DK2413954T3/en
Priority to RU2011142268/15A priority patent/RU2536223C2/en
Priority to JP2012502396A priority patent/JP5687266B2/en
Priority to PCT/AU2010/000391 priority patent/WO2010111753A1/en
Priority to CN2011800017312A priority patent/CN102711797A/en
Priority to BRPI1006748A priority patent/BRPI1006748A2/en
Priority to IL215460A priority patent/IL215460A/en
Priority to ZA2011/07820A priority patent/ZA201107820B/en
Priority to HK12105842.5A priority patent/HK1165271A1/en
Priority to US14/252,818 priority patent/US20140235541A1/en
Abandoned legal-status Critical Current

Links

AU2009901425A 2009-04-02 2009-04-02 Compositions and methods for treatment of aortic fibrosis Abandoned AU2009901425A0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
BRPI1006748A BRPI1006748A2 (en) 2009-04-02 2010-04-06 prophylactic or therapeutic treatment method for aortic fibrosis in an individual, vasoactive intestinal peptide (vip), use of vasoactive intestinal peptide (vip), method for reducing collagen formation or for enhancing collagen degradation in an individual's ortho, and , composition for the prophylactic or therapeutic treatment of aortic fibrosis
KR1020117025945A KR101627008B1 (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis
RU2011142268/15A RU2536223C2 (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aorta fibrosis
US13/262,064 US8729020B2 (en) 2009-04-02 2010-04-06 Methods for the treatment of aortic fibrosis with VIP fragments
NZ595726A NZ595726A (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis
EP10757953.4A EP2413954B1 (en) 2009-04-02 2010-04-06 Composition comprising vip or its active fragments for use in treating aortic fibrosis
SG2011070778A SG174966A1 (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis
MYPI2011004649A MY180681A (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis
AU2010230862A AU2010230862B2 (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis
ES10757953.4T ES2462501T3 (en) 2009-04-02 2010-04-06 Composition comprising VIP or its active fragments for use in the treatment of aortic fibrosis
MX2011010341A MX2011010341A (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis.
DK10757953.4T DK2413954T3 (en) 2009-04-02 2010-04-06 A composition comprising VIP or its active fragments for use in the treatment of aortic fibrosis
CA2757076A CA2757076C (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis comprising vasoactive intestinal peptide (vip) or functional vip fragments
JP2012502396A JP5687266B2 (en) 2009-04-02 2010-04-06 Compositions and methods for the treatment of aortic fibrosis
PCT/AU2010/000391 WO2010111753A1 (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis
CN2011800017312A CN102711797A (en) 2009-04-02 2010-04-06 Compositions and methods for treatment of aortic fibrosis
IL215460A IL215460A (en) 2009-04-02 2011-10-02 Use of compositions comprising vip in the manufacture of medicaments for prophylactic or therapeutic treatment of aortic fibrosis
ZA2011/07820A ZA201107820B (en) 2009-04-02 2011-10-25 Compositions and methods for treatment of aortic fibrosis
HK12105842.5A HK1165271A1 (en) 2009-04-02 2012-06-14 Composition comprising vip or its active fragments for use in treating aortic fibrosis
US14/252,818 US20140235541A1 (en) 2009-04-02 2014-04-15 Compositions and methods for treatment of aortic fibrosis

Publications (1)

Publication Number Publication Date
AU2009901425A0 true AU2009901425A0 (en) 2009-04-23

Family

ID=

Similar Documents

Publication Publication Date Title
EP2482814A4 (en) Methods and compositions for treatment of ocular fibrosis
AU2009221838A8 (en) Implants and methods of use
PL2182981T3 (en) Methods and compositions for treatment and diagnosis of fibrosis
EP2615932A4 (en) Compositions and methods of treating edible matter and substrates therefor
EP2429948A4 (en) Aerogel compositions and methods of making and using them
EP2603202A4 (en) Compositions and methods for treatment of taupathy
EP2533926A4 (en) Bur and method of making same
HK1166305A1 (en) Compositions and methods for the treatment of inflammation
IL214455A0 (en) Methods and compositions for treatment of neovascularization
WO2010123759A9 (en) Compositions and methods for treating burns
AU2010260585A8 (en) Compositions and methods for treatment of Multiple Sclerosis
IL247929B (en) Stable sns-595 compositions and methods of preparation
ZA201203060B (en) Composition and method of delivery
ZA201107820B (en) Compositions and methods for treatment of aortic fibrosis
EP2563923A4 (en) Compositions and methods for reduced scarring and for treatment of fibrosis
EP2462131A4 (en) Compositions and methods for treating beta-amyloid related diseases
AU2009901425A0 (en) Compositions and methods for treatment of aortic fibrosis
AU2009901447A0 (en) Composition and method of treatment
AU2010902965A0 (en) Antipsoratic composition and method of treatment
AU2010901445A0 (en) Composition and method of treatment
AU2009904460A0 (en) Methods of treatment
AU2009902633A0 (en) Methods of treatment
AU2009905173A0 (en) Methods of treatment
AU2009903360A0 (en) Method of Treatment
AU2009905930A0 (en) Methods and Preparation and Uses of Xanthorrhoeaceae Compositions